|
Originally published In Press as doi:10.1074/jbc.M203433200 on August 12, 2002
J. Biol. Chem., Vol. 277, Issue 42, 39119-39127, October 18, 2002
Trachynilysin, a Neurosecretory Protein Isolated from Stonefish
(Synanceia trachynis) Venom, Forms Nonselective Pores in
the Membrane of NG108-15 Cells*
Gilles
Ouanounou §,
Michel
Malo §,
Jacques
Stinnakre ,
Arnold S.
Kreger¶, and
Jordi
Molgó
From the Laboratoire de Neurobiologie Cellulaire et
Moléculaire, UPR 9040 CNRS, 1 avenue de la Terrasse, 91198 Gif-sur-Yvette Cedex, France and the ¶ Department of Epidemiology
and Preventive Medicine, University of Maryland School of Medicine,
Baltimore, Maryland 21201-1595
Received for publication, April 9, 2002, and in revised form, August 9, 2002
 |
ABSTRACT |
Trachynilysin, a protein toxin isolated from the
venom of the stonefish Synanceia trachynis, has been
reported to elicit massive acetylcholine release from motor nerve
endings of isolated neuromuscular preparations and to increase both
cytosolic Ca2+ and catecholamine release from chromaffin
cells. In the present study, we used the patch clamp technique to
investigate the effect of trachynilysin on the cytoplasmic membrane of
differentiated NG108-15 cells in culture. Trachynilysin increased
membrane conductance the most when the negativity of the cell holding
membrane potential was reduced. The trachynilysin-induced current was
carried by cations and reversed at about 3 mV in standard
physiological solutions, which led to strong membrane depolarization
and Ca2+ influx. La3+ blocked the trachynilysin
current in a dose-, voltage-, and time-dependent manner,
and antibodies raised against the toxin antagonized its effect on the
cell membrane. The inside-out configuration of the patch clamp
technique allowed the recording of single channel activity from which
various multiples of 22 pS elementary conductance were resolved.
These results indicate that trachynilysin forms pores in the NG108-15
cell membrane, and they advance our understanding of the toxin's mode
of action on motor nerve endings and neurosecretory cells.
 |
INTRODUCTION |
Neurotoxins have proved to be valuable tools for understanding
molecular mechanisms involved in physiological processes, and their use
has been instrumental in the purification and identification of key
protein components of excitable membranes and synapses (1-3). Among
the neurotoxins that promote neurotransmitter release, the most studied
has been -latrotoxin
( -LTX)1 (for recent
reviews, see Refs. 4 and 5), a 120 kDa protein purified from the venom
of the black widow spider (Lactrodectus mactans
tredecimguttatus), which is known to trigger
Ca2+-dependent and -independent release of a
variety of neurotransmitters and hormones (6-11). -LTX
forms nonselective cationic pores in planar lipid bilayers (12-14) and
in the cytoplasmic membrane of differentiated PC12 (15) and
neuroblastoma cells (16). In addition, two families of -LTX
receptors that facilitate pore formation in biological membranes (17,
18) have been identified, i.e. neurexins (19, 20) and
latrophilins (21-24), and the pores are involved in the toxin's
massive release of neurotransmitters (4, 5, 7, 9, 11).
Trachynilysin (TLY), a 159 kDa membrane-perturbing (hemolytic) toxic
protein isolated from the venom of the stonefish Synanceia trachynis, also greatly increases quantal acetylcholine release from motor nerve endings (25, 26) and catecholamine secretion from
large dense-core vesicles of chromaffin cells (27). However, contrary
to -LTX, these two types of release are
Ca2+-dependent. Interestingly, neither TLY (25)
nor -LTX (28) affects the number of large dense-core vesicles
containing neuropeptides in motor nerve endings despite the
depletion of small clear synaptic vesicles. TLY has also been reported
to raise the intracellular Ca2+ concentration in cultured
mouse hippocampal neurons (29) and adrenal chromaffin cells (27).
Simultaneous blockade of L, N, and P/Q voltage-dependent
Ca2+ channels caused only a minor reduction of TLY-induced
catecholamine secretion and little change in Ca2+ signals
(27), and removal of extracellular Ca2+ and addition of
EGTA or La3+ completely abolished both secretion and
Ca2+ signals. Moreover, depletion of intracellular
Ca2+ stores with caffeine inhibited TLY-induced
catecholamine secretion by chromaffin cells. These results suggest that
transmembrane Ca2+ influx and the resulting mobilization of
intracellular Ca2+ stores are required for TLY-induced
secretion (27). To determine the mechanism for the Ca2+
influx, we decided to determine whether TLY activates existing ion
channels or forms pores in the plasma membrane. Other stonefish toxins;
i.e. stonustoxin from Synanceia horrida venom
(30) and verrucotoxin from Synanceia verrucosa venom (31),
are known to exert their hemolytic activity through pore formation
(32).
To the best of our knowledge, voltage clamp studies have not been
performed previously with any of the stonefish toxins. In the present
studies, the membrane effects and the ability of TLY to form pores were
investigated using the patch clamp technique and differentiated
NG108-15 hybrid cells (33).
 |
EXPERIMENTAL PROCEDURES |
Cell Culture--
Undifferentiated neuroblastoma × glioma
NG108-15 hybrid cells were grown in monolayer cultures using
Dulbecco's modified Eagle's medium supplemented with 5% fetal calf
serum, 100 µM hypoxanthine, 0.4 µM
aminopterin, 16 µM thymidine, 2 mM glutamine,
and 3 µM glycine, as described previously (34). Three
days before performing the experiments, the cells were differentiated
by adding 0.5 mM dibutyryl cyclic adenosine-monophosphate
(Sigma-Aldrich) to the medium and reducing the serum concentration to
1%. The cultures were maintained at 37 °C in a humidified
atmosphere containing 95% air, 5% CO2. Tissue culture
reagents were purchased from Invitrogen.
Trachynilysin--
TLY was purified from stonefish (S. trachynis) venom by sequential anion exchange, fast protein liquid
chromatography (FPLC), and size exclusion FPLC (25). Aliquots of the
purified toxin (~2 mg of protein/ml) in 10 mM
Tris-HCl-buffered saline (pH 7.4) containing 5% glycerol were stored
at 60 °C. Before being used in the electrophysiological
experiments, TLY was diluted with the standard physiological solution.
A fast perfusion system allowed changing the solution around the
recorded cell in a fraction of a second. Inside-out patch clamp
experiments used TLY diluted with the standard solution filling the
patch pipette.
Anti-TLY Antibodies--
A female New Zealand White rabbit was
injected subcutaneously with a water-in-oil emulsion composed of equal
parts of Hunter's TiterMax adjuvant (Sigma) and a solution of purified
TLY. Injections were performed on (i) days 0 and 17 with 32 and 158 µg of toxin protein, respectively, (ii) days 31 and 52 with 317 µg
of toxin, and (iii) days 88, 110, and 131 with 1.14 mg of toxin.
The rabbit was sedated and exsanguinated on day 139, and the anti-TLY
serum was lyophilized and stored at 4 °C. Negative control, normal
serum was obtained from a rabbit injected (according to the above
protocol) with an emulsion containing only adjuvant and buffer, and the serum was lyophilized and stored at 4 °C. Immunoglobulin G (IgG) antibodies were isolated from reconstituted sera (75 mg/ml deionized water) with an ImmunoPure IgG purification kit (Pierce). The
specificity of the anti-TLY IgG was revealed by (i) Western blots
probed with the anti-TLY and control IgG preparations and (ii) studies
examining the ability of the two preparations to neutralize TLY
in vitro hemolytic activity, as described in the below
protocols and under "Results" (Fig. 2, A and
B).
Extraction of NG108-15 Cell Proteins--
Differentiated
NG108-15 cells (2.5 × 106) in culture were
extensively washed twice with phosphate-buffered saline, homogenized in
10 mM Tris buffer (pH 7.1), and centrifuged (800 × g, 10 min) to remove the nuclei. The protein content of the
supernatant fluids was determined by the Lowry method (35) before
aliquots of the fluids were used in the Western-blotting experiments.
Western Blotting--
TLY (0.5 µg of protein/lane) and the
protein extract (6 µg/lane) from NG108-15 cells were analyzed under
reducing conditions (10% -mercaptoethanol) by SDS-PAGE with a 12%
acrylamide gel. After electrotransfer (4 °C, overnight, 0.2 A) of
the separated protein bands onto a nitrocellulose membrane, the
membrane was blocked (8 h, 4 °C) with Tris-buffered saline
containing 0.1% Tween 20, 5% (w/v) skimmed milk powder, and 1% (w/v)
bovine serum albumin, and it was probed (12 h, 4 °C) with the
anti-TLY or control IgG preparation diluted (1:500) in the blocking
buffer. The rabbit IgG-probed membranes were washed with Tris-buffered
saline, and bound antibodies were detected after probing (2 h, 4 °C)
with a diluted (1:1000) peroxidase-labeled, anti-rabbit IgG preparation using an enhanced chemiluminescence detection system (ECL, Amersham Biosciences) according to the manufacturer's instructions.
Neutralization of TLY Hemolytic Activity--
One hundred and
1000 hemolytic units of TLY, contained in 1 ml volumes of Tris-buffered
saline (pH 7.4) supplemented with crystalline bovine albumin (1 mg/ml),
were incubated (15 min, 37 °C) with various amounts of anti-TLY IgG
and control IgG, and the residual hemolytic activity of the incubated
mixtures was determined against rabbit erythrocytes as previously
described (36).
Patch Clamp Recordings--
Whole-cell and inside-out patch
clamp recordings were performed at room temperature (20-22 °C) as
previously described (37). Pipettes were made from borosilicate glass
(Clark Electromedical Instrument, Reading, England) and pulled on a
BP-7 puller (Narishige, Osaka, Japan). The patch electrodes filled with
physiological saline solutions had a resistance of 3-5 M . Membrane
currents were recorded with a RK-300 patch clamp amplifier (Biologic,
Claix, France), and they were filtered with an 8-pole low pass Bessel filter (Biologic, ibid.) at 8 kHz for whole-cell
recordings and at 3 kHz for inside-out patch recordings. The filtered
signals were digitized by a 12 bit A/D converter (Labmaster DMA,
Scientific Solutions Inc., Mentor, OH) and stored using pCLAMP 5.5 software (Axon Instruments, Union City, CA). Whole-cell and inside-out patch data were acquired at a sample rate of 1 and 10 kHz,
respectively. Recordings were analyzed using Origin 5 software
(Microcal Software Inc., Northampton, MA), taking advantage of the
built-in regression functions and of the Labtalk programming language.
The standard external and internal solutions for whole-cell recordings
had the following compositions: 154 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES (pH 7.4)
(external solution) and 135 mM KCl, 5 mM
MgCl2, 10 mM EGTA, 10 mM HEPES (pH
7.2) (internal solution). The internal solution was filtered through
0.2 µm Millex filters (Millipore, Saint-Quentin en Yvelines, France).
The osmotic pressure of the internal and external solutions were
295-305 mosmol and 305-315 mosmol, respectively, as measured with a
freezing point osmometer (Knauer, Berlin, Germany). The solutions used to determine the ionic selectivity of the TLY-induced current are shown
in Table I. For inside-out patch recordings, the external solution was
also used as the internal solution.
Ionic Selectivity Determination--
To minimize the
contribution of voltage-gated K+ channels to the
macroscopic current, some patch clamp experiments were performed at a
holding potential of +60 mV. Under this condition, the transient voltage-dependent currents, including K+
currents (38, 39), were inactivated by about 95% 2 min after changing
the holding potential. Thus, the different
voltage-dependent currents were limited without using any
pharmacological agent that could interact with the toxin.
To determine the ionic selectivity of the TLY-induced current, its
reversal potential was measured in solutions of various ionic
composition using ramp-potentials (150 mV/s) from +60 to 60 mV.
Derived from the Goldman-Hodgkin-Katz flux equation (40, 41), Equation 1 (42) gives the reversal potential of a cationic current as a function
of the concentration and permeability of each ion species.
|
(Eq. 1)
|
In this equation, the terms in square brackets are ion
concentrations, PS is the permeability of the
S ion species, T is the absolute temperature, R
and F are the usual gas and Faraday constants, and i and
o are the intra- and extracellular compartments, respectively. Ion activities are used rather than concentrations, as in
Equation 2 (43). The activity coefficients used for Na+,
K+, Ca2+, and Mg2+ were 0.75, 0.75, 0.25, and 0.25, respectively.
|
(Eq. 2)
|
Quantification of Macroscopic Current Steps and Low Frequency
Fluctuations--
The macroscopic current steps were counted and
measured using routines written by G. Ouanounou (this paper) in the
Labtalk programming language of Origin software. Current step
transitions were detected by computing average currents on a 50-100-ms
time window before and after any given point and calculating the
difference. A transition occurred when the difference was higher than
twice the variance of the "before" window.
To quantify the current variations that did not occur in steps, each
detected step was subtracted from the ensuing samples of the recording,
which led to a smoothed trace deprived of step transitions. In other
words, the new trace exhibited only low frequency components.
Derivation of that signal allowed us to dissociate the changes of
membrane conductance into increasing and decreasing components
according to the sign of the derivative. Separate integration of the
two components of the derivative over the entire analyzed period gave
the cumulative currents corresponding to each component.
Noise Analysis--
Noise analysis was performed using the fast
Fourier transform module included in Origin 5 software after filtering
off the lower frequencies. The analyzed periods were divided into
sections of 1024 samples, and the resulting power spectra were
averaged. The mean spectrum, performed on similar base-line sections,
was subtracted before fitting to Lorentz Equation 3,
|
(Eq. 3)
|
where S(f) is the power, f is
the frequency, and S0 is the constant to which the function
tends for low frequencies.
The mean channel lifetime ( ) was computed from the cut-off
frequency (fc).
|
(Eq. 4)
|
The elementary conductance was calculated from the variance
( 2) and the mean current (Im) of the
analyzed signal,
|
(Eq. 5)
|
where Vm is the membrane potential, and
Erev is the reversal potential.
 |
RESULTS |
Whole-cell Recording of Membrane Currents during TLY
Action--
To determine the effect of TLY on ionic permeability,
membrane currents of NG108-15 cells were recorded in the standard
external solution using the whole-cell configuration of the patch clamp technique at a holding potential of 60 mV. An inward current developed about 1 min after the addition of 12 nM TLY to
the external medium. In the continuous presence of TLY, the induced
current rapidly became too large to be recorded accurately. Because of the irreversibility of the TLY effect, the toxin was applied for just 1 min. Under these conditions, the TLY-induced current was limited to a
recordable intensity range. A 1 min exposure to 12 nM TLY
appeared to be just higher than a threshold duration, since shorter
applications of that TLY concentration had no effect other than an
increase in electrical noise (data not shown). The threshold duration
of toxin exposure could be reached by successive applications, alternating TLY-containing medium with TLY-free medium. This suggests that a minimal number of TLY molecules has to bind to the membrane to
produce the membrane effect, and this may partly explain the latency of
the effect of the toxin. After 1 min of exposure to TLY, the current
increased in a stepwise manner to about 500 to 1000 pA and then
fluctuated around this range (Fig.
1A).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Whole-cell recordings of the membrane current
elicited by exposure of NG108-15 cells to TLY. In this figure as
in the others 12 nM TLY was applied for 1 min at a holding
potential of 60 mV. A, typical example of the onset of
TLY-induced current. The horizontal bar above the
trace shows the time of toxin application. B,
step-like activities appearing at different time bases. The top
trace is from the same cell as that in A. C,
time distribution of the membrane current induced by TLY. Three
recordings were pooled, including the one shown in A, after
the base line was subtracted. Currents were binned in 1 pA classes
(see "Results"), and the frequency was normalized for the
total recording time. The traces in black
represent the Gaussian fits of the different peaks. Inset,
plot of the modes of the 15 peaks shown in the histogram
versus their ascending rank order. The straight
line represents the linear regression across all points.
|
|
Details of the time course of the TLY-induced current at various time
scales are shown in Fig. 1B. The TLY-induced activity exhibited macroscopic steps of various sizes that coexisted with current fluctuations without visible steps. Thus, two types of current
variations, each with its own frequency domain, compose the TLY-induced
current. Despite a large spectrum of step sizes and low frequency
variations, visual inspection suggested that the membrane current
presented preferential values. To support this view, the first minutes
of three recordings were pooled and analyzed as follows. The current
was binned in 1 pA-wide classes, and the relative number of samples at
any of these levels was computed and plotted versus the bin
size (Fig. 1C). The peaks revealed by this time-distribution
showed the most frequent intensities of the TLY-induced current. The
modes of these peaks, determined by a Gaussian-fitting regression,
appeared to be regularly spaced. The mode values were plotted as a
function of their rank when sorted in ascending order, and they were
fitted with a linear regression equation (inset, Fig.
1C). The slope of the regression line, 27 pA, represents the
mean increment between peaks, which suggests that the TLY current is
composed of multiples of a common component.
The presence of steps and low frequency fluctuations precluded a deeper
analysis of the TLY-induced channel-like activity. However, another
type of analysis was performed, as shown later.
Anti-TLY Antibodies Suppress the Current Induced by
TLY--
Before using the anti-TLY IgG preparation in our
electrophysiological experiments, its specificity was evaluated by
Western blotting and by determining its ability and the ability of the control IgG preparation to neutralize TLY in vitro hemolytic
activity. The Western blotting experiments revealed (Fig.
2A) that (i) the anti-TLY IgG
bound to TLY - and -subunits but not to any of the proteins
isolated from NG108-15 cells, and (ii) labeling of the toxin subunits
was not observed when the control IgG preparation was used as a probe.
The studies examining the specificity of the anti-TLY IgG preparation
ability to neutralize TLY in vitro hemolytic activity
revealed (Fig. 2B) that incubating 100 and 1000 hemolytic
units of TLY with ~93 and 698 µg, respectively, of anti-TLY IgG
eliminated ~90% of the toxin in vitro hemolytic activity.
However, incubating 100 hemolytic units of TLY with ~1.34 mg of
control IgG did not eliminate any hemolytic activity.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 2.
Characterization of anti-TLY antibodies and
their ability to inhibit the TLY-induced current. A,
Western blot analysis of TLY (0.5 µg of protein/lane) and of proteins
(6 µg/lane) isolated from differentiated NG108-15 cells. Protein
bands labeled with IgG were detected with an enhanced chemiluminescence
detection system after sequential probing with (i) anti-TLY IgG or
control IgG and (ii) peroxidase-labeled, anti-rabbit IgG (as
described under "Experimental Procedures"). The molecular weight
markers are indicated. B, neutralization of TLY in
vitro hemolytic activity by anti-TLY IgG (determined as described
under "Experimental Procedures"). The data points were fitted by
exponential functions. HU, hemolytic units. C,
whole-cell recording in the standard solution from a cell to which TLY,
control IgG (95 µg/ml, final concentration), and anti-TLY IgG (95 µg/ml, final concentration) were applied. The bars show
the duration of the applications. The holding potential was 60
mV.
|
|
Our observation that anti-TLY antibodies neutralized TLY hemolytic
activity prompted us to determine whether they could also affect the
TLY-induced current. TLY was applied (as described under
"Experimental Procedures"), and after the macroscopic
induced-current developed, anti-TLY IgG (95 µg/ml, final
concentration) was added to the external solution. The TLY-induced
current progressively decreased in all 4 cells tested (each from a
different culture) until it was completely inhibited within 2-4 min
(Fig. 2C). However, control, normal IgG (95 µg/ml, final
concentration) did not affect the current induced by TLY or the
inhibitory action of a subsequent application of anti-TLY IgG (Fig.
2C). In two of the cells, continuous wash-out of the
antibodies allowed about 30% recovery of the TLY-induced current
before the gigaseal was lost (data not shown). In the other two cells,
the seal was lost at the beginning of the wash-out period. In addition,
exposure of the cells to anti-TLY IgG followed by wash-out (which had
no membrane effect) did not prevent the membrane response to subsequent
exposure to TLY (data not shown). These results suggest that the
anti-TLY IgG bound to the toxin in a reversible manner, and they
confirm that TLY binds irreversibly to the cell membrane.
Macroscopic Steps and Low Frequency Current Variations Induced by
TLY--
Because the membrane current returned to the initial base
line in the presence of anti-TLY antibodies, we assumed that all of the
TLY-induced increases in conductance were exactly balanced by
conductance decreases, and this situation prompted us to assess the
proportion of steps and low frequency fluctuations involved in the
conductance changes. Therefore, using the algorithm described under
"Experimental Procedures," two recordings (including the one shown
in Fig. 2) were decomposed into their step and low frequency components
(see Fig. 3, A-B), and the
two components were separately analyzed. The number of detected upward
events represented only 72% of the downward events. Furthermore, the
respective amplitude distributions differed, i.e. the upward
events were smaller than the downward events (Fig. 3C). This
difference was statistically significant, as demonstrated by the
Kolmogorov-Smirnov test performed on the cumulative frequency
distribution (p 0.01). On the whole, the sum of the
closing (upward) events corresponded to only 57% of the opening
(downward) events. This feature resulted in a global downward
deflection of the step component, as shown in Fig. 3B (bottom trace). The analysis did not reveal a common
substep; however, the frequency distributions (Fig. 3C,
insets) revealed that the most frequent step transitions
occurred in the 27 pA class, which may explain the preferential levels
of the global TLY-induced current already noticed (Fig. 1C)
and characterized by a 27 pA increment.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 3.
Decomposition and analysis of the macroscopic
TLY-induced current. A, expanded fragment of the
recording shown in Fig. 2, with gray dots limiting the step
transitions detected by the algorithm described under "Experimental
Procedures." B, separation of the step (bottom
trace) and low frequency (top trace) components of the
recording shown in A. The top trace was obtained
by subtracting the bottom trace from the initial recording.
C, cumulative frequency distributions of downward ( ) and
upward ( ) current step transitions extracted from two different
recordings, including the one shown in Fig. 2. The insets
show the relative frequency-distributions of downward and upward
transitions. Bin size was 2 pA. The two distributions are significantly
different according to the Kolmogorov-Smirnov test (p 0.01). D, differentiation of the low frequency component
of the full trace shown in Fig. 2. The positive and negative parts of
the derivative are separately plotted for clarity.
|
|
The low frequency component was analyzed by derivation and by separate
integration of the positive and negative parts of the derivative (Fig.
3D). This analysis allowed the separation of periods of
increasing and decreasing membrane conductance; i.e. the
integral of the positive derivative gives the cumulative current, which
corresponded to membrane conductance decreases. Conversely, the
integral of the negative derivative corresponded to membrane conductance increases. The membrane conductance increases represented 22% of the conductance decreases, which led to a global upward deflection of the low frequency component of the TLY current, as seen
in Fig. 3B (top trace). Thus, during TLY action,
85% of the membrane conductance increases occurred by steps, and 15% occurred by low frequency fluctuations, whereas steps and low frequency
fluctuations contributed almost equally (49 and 51%, respectively) to
the membrane conductance decreases.
Influence of the Membrane Potential on the Conductance Induced by
TLY--
All of our previous studies were performed at a membrane
potential of 60 mV. Therefore, we decided to examine whether membrane potential influences TLY-induced changes in membrane conductance. At
positive potentials, the toxin-induced current was relatively stable
and did not exhibit macroscopic steps (only fluctuating at low
frequency), in contrast to what was observed at negative potentials
(Fig. 4A). Moreover, the TLY
membrane conductance increase was greater at positive than at negative
holding potentials.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 4.
Influence of the holding potential
on the membrane conductance changes induced by TLY. A,
whole-cell recordings of the toxin-induced current during step
potentials from +60 to 60 mV. Four recordings obtained with the same
cell are shown after subtraction of the current recorded during control
steps (before toxin application). Note that the current steps are only
visible at 60 mV. B, current-voltage relationship of
TLY-induced current under steady-state conditions. The holding
potential was stepped-down by 10 mV every 40 s, from +50 to 100
mV, and the control current (using this protocol) was subtracted. The
ordinate represents the mean steady-state current (measured
during the last 20 s of each potential change) relative to the
mean current recorded at +50 mV. Each point represents the mean ± S.E. from data collected in eight different cells. Note that the
membrane conductance increase induced by TLY increased as the
negativity of the membrane potential was reduced.
|
|
To determine the kinetics of this voltage sensitivity, 60 s step
potentials were applied (from the holding potential of +60 mV to the
test potential of 60 mV) with different cells previously treated with
TLY (Fig. 4A). Transmembrane currents recorded before toxin
application were subtracted from currents recorded in the presence of
TLY. When the membrane potential was stepped from +60 to 60 mV, the
TLY-induced current reversed and then decreased to about 20% of its
initial value in ~20 s. The mean current calculated from four
recordings (Fig. 4A) was fitted with a single exponential function that had a decay time constant of 5.32 ± 0.05 s
(95% confidence interval). Notably, a step from a holding potential of
60 mV to a test potential of +60 mV yielded different kinetics for
the membrane conductance changes, i.e. the membrane current increased abruptly about 1 min after the potential change without exhibiting current steps (data not shown).
To determine the current-voltage relationship of the TLY-induced
current at the steady state, the potential was changed from +50 mV to
100 mV in 10 mV steps lasting 40 s. The average current during
the last 20 s of each step was normalized to the averaged current
recorded at +50 mV. As shown by the current-voltage relationship (Fig.
4B), the TLY-induced current reversed at 3 mV in the
standard solutions, which suggested that the induced conductance did
not have ionic selectivity. The average current was constant from 100 to 40 mV, thus indicating that the membrane conductance increased as the negativity of the membrane potential was reduced. At
potentials more positive than the reversal potential, the membrane conductance was almost constant. This corresponds to a so-called "outward rectification."
Ionic Selectivity of TLY-induced Current--
To determine the
ion(s) taking part in the TLY-induced current, the reversal potential
was measured in solutions of various ionic composition using ramp
potentials (from +60 to 60 mV) in a whole-cell configuration. Ramp
potentials performed before TLY application were used as controls (Fig.
5, middle trace). The TLY-induced current reversed at about 3 mV (n = 17)
in standard solutions (Fig. 5, bottom traces), as was
observed previously at the steady state. The reversal potentials of the
TLY-induced current recorded in external solutions of various ionic
composition are shown in Table I. For
each cell, the reversal potential was determined in the external
standard solution and in one of the test solutions. Methanesulfonate
substitution for Cl did not affect the reversal potential
(n = 5), whereas substituting half of the NaCl content
with sucrose significantly shifted the reversal potential to a more
negative value (n = 3). Thus, neither methanesulfonate
nor Cl contribute to the TLY current. In contrast, TLY
caused all of the physiological cations to permeate through the
membrane. The relative permeability values, for which calculated
reversal potentials using Equation 2 fit best with experimental values,
were PK/PNa = 1.3, PCa/PNa = 1.4, and
PMg/PNa = 1.4.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Determination of reversal potential of the
TLY-induced current. Upper trace, ramp potentials (150 mV/s, +60 to 60 mV) applied to determine the reversal potential.
Middle trace, control membrane current recorded before TLY
application. Lower traces, recordings of the TLY-induced
current from one cell obtained at various times after TLY application
(after subtraction of the control current). The current amplitude scale
applies to the middle and bottom recordings.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Reversal potential (Erev) of the TLY-induced current in media
of various ionic compositions
For each cell, the TLY-induced current Erev was determined in
the standard solution and in one of the test solutions, using the
protocol for the Fig. 5 data. All reversal potentials were graphically
determined.
|
|
La3+ Blocks the Current Induced by TLY--
The
La3+ ion is known to inhibit TLY-induced release of
catecholamines from chromaffin cells (27) and the -LTX-induced
current (11, 17) and to perturb the structure of -LTX pores (11, 44). Therefore, it was of interest to determine whether the current
induced by TLY in NG108-15 cells was affected by this cation. At 60
mV, 1 mM La3+ added to the external medium
completely blocked the current induced by TLY. In the presence of 100 µM La3+, the current returned to the base
line, suppressing all low frequency current fluctuations and leaving
only fast current transients (Fig.
6, A-B). Lower
La3+ concentrations partially affected the TLY-induced
current. Because of the current fluctuations already described, the
La3+ effect was quantified by rationing the mean current
during La3+ application to the control current. A Boltzmann
equation fit of the data points, obtained with various La3+
concentrations, gave an EC50 = 512 ± 56 nM (95% confidence limits, Fig. 6C). At all
concentrations used, the blockade of the TLY-induced current by
La3+ was rapidly reversed by washing with the standard
medium.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Blockade of TLY-induced current by
La3+. A and B, whole cell
recording of the TLY-induced current in the presence of 100 µM La3+ in the external solution (upper
bar) at 60 mV. Note the persistence of current transients (also
visible in B) on expanded scales. C,
dose-response curve for La3+ blockade of the TLY-induced
current (holding potential, 60 mV). The data points represent the
means ± S.E. of the relative currents calculated from 20 s period
recordings made before and after the application of the
La3+ concentrations (data were obtained from 4 different
cells). The data points were fitted by the Boltzmann equation, and they
gave an EC50 = 512 ± 56 nM (95%
confidence limits).
|
|
A closer examination of the La3+ blockade at 100 µM showed that the transient currents described above
exhibited a fast on-current followed by an exponential decay (Fig.
6B). This suggests that the transients correspond to the
current steps described above, which are blocked in a
time-dependent manner by La3+ ions. In
addition, the use of the ramp-potential protocol revealed that, in the
presence of La3+ (100 µM), the current
exhibited an outward rectification (data not shown), thus indicating
that the La3+ effect is voltage-dependent.
Elementary TLY-induced Current--
To determine whether the
observed macroscopic changes in membrane conductance were due to
channel-like activity and whether this activity could explain the time
course of the macroscopic TLY-induced current, elementary currents were
recorded from membrane patches using the "inside-out"
configuration. A drop of buffered TLY solution was deposited at the
back of the pipette previously filled with standard external solution.
The time necessary for TLY to diffuse to the pipette tip allowed the
sealing of the inside-out patch clamp configuration and the
confirmation of the absence of endogenous ionic conductances in the
membrane patch.
At a pipette potential of 60 mV (i.e. a
positive membrane potential), only one channel conductance (22 pS) was
detected; i.e. several minutes after inside-out patch
achievement, a single channel activity developed (Fig.
7, A-A'), and the number of
channels (as well as the opening/closing rate) then increased rapidly. At a pipette potential of +60 mV (i.e. negative
membrane potential), several channel conductances were detected. The
induction of channel activities began with a 22 pS elementary
conductance (Fig. 7, B-B'). After relative stabilization in
the open state of 4-8 channels of 22 pS, bursts of 72 and 86 pS
channel activity appeared from this current level as base line (Fig. 7,
C-D, C'-D'). As time progressed,
channel activity became complex and showed elementary conductance
multiples of ~22 pS and an increased opening/closing rate. However,
periods of single channel activity alternated with periods during which
the current continuously changed without evident channel activity but
with an increased noise level (Fig. 7E). During these
periods, the current evolved between two levels corresponding to the
open and closed states of 72 and 86 pS channels, without summation with
these channel activities. The frequency spectrum of these periods
(provided by fast Fourier transform noise analysis) could be fitted by
a Lorentz equation, which indicated that the noise resulted from
summation of discrete events (see Ref. 45). These events had a mean
open time of about 3.5 ms and an elementary conductance of ~22 pS. It
should be emphasized that this analysis corresponds to the early stages
of TLY activity, because the patch current rapidly became too complex
to analyze.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 7.
Elementary TLY-induced currents.
Elementary currents were recorded with the inside-out patch clamp
configuration. The pipettes were filled with the standard external
solution, and a drop of TLY was deposited at the back of the pipette
before initiating the sealing procedure. A, induction of
channel activities just after inside-out patch achievement at a pipette
potential of 60 mV. A', probability distribution (0.1 pA
bin size) of the current shown in A ( = 22 pS).
B, as in A, but at a pipette potential of +60 mV
in another cell. B', probability distribution (0.1 pA bin
size) of the current shown in B ( = 22 pS).
C-D, the same patch and same potential as in B;
new channel activities are superimposed with the current due to the
constant opening of a few 22 pS channels. C'-D',
probability distribution (0.1 pA bin size) of the current shown in
C-D ( = 86, 72 pS, respectively). E, the
same cell as in B; shows periods of unresolved channel
activity (between arrows) alternating with periods similar
to those shown in C-D. E', frequency spectrum
obtained by fast Fourier transform of several recordings similar to
that shown between the arrows in E. The data
points are fitted to a Lorentz equation, with S(0) = 1.58 10 5 pA2·s, and
fc = 45 Hz.
|
|
This study shows that the TLY-induced macroscopic current is due at
least in part to ion channel-like activity. Interestingly, at the
elementary level as at the macroscopic one TLY activity appears to be
constituted of various components at negative membrane potentials,
whereas only a single component is detectable at positive potentials.
 |
DISCUSSION |
The present study demonstrates that brief exposure to TLY induces
after a short latent period a potent and irreversible increase in the
membrane conductance of NG108-15 cells. Under voltage clamp conditions,
the TLY-induced increase in membrane conductance leads to a
transmembrane cationic current which, when measured in standard media,
reverses at a membrane potential of 3 mV and exhibits an outward
rectification. A 1 min exposure to 12 nM TLY appeared to be
the time threshold before which time TLY had no apparent effect, and
this minimum duration could be reached by successive exposures. This
observation suggests that TLY binds irreversibly to the membrane and
that a threshold amount of TLY-bound molecules presumably is needed to
alter membrane permeability.
Two hypotheses may be proposed to explain the above-mentioned results;
either TLY activates one or several types of endogenous ion channels or
TLY forms ionic pores by insertion into the cell membrane. Our
experimental results revealed that (i) the TLY-induced macroscopic
current is made of slow fluctuations and current steps of up to 160 pA
(at 60 mV), making it particularly unstable, (ii) TLY elicited
channel activity in membrane patches devoid of endogenous channels, and
(iii) the observed TLY effect required a threshold amount of bound
toxin. These features are inconsistent with the idea that TLY forms
pores by activating preexisting channels. Indeed, the observed current
steps correspond to a conductance change of about 2.8 nS, which is much
higher than that of any endogenous single channel conductance described
to date. Furthermore, considering the irreversibility of the TLY
effect, it is difficult to understand or explain how preexisting
channels activated by TLY would fluctuate as observed. Also, features
similar to those described above have been described for exogenous
polypeptides, such as equinatoxin II (46) and -LTX (12, 15-17), and
for endogenous polypeptides such as amylin (47), all of which are known
to form pores by insertion into the cell membrane. Thus, our data
support the idea that the TLY-elicited pore activity we observed is
caused by insertion of TLY into the cell membrane rather than by
TLY-induced activation of preexisting silent channels.
Experiments using various holding potentials revealed a large
difference in the time course of the TLY-induced current depending on
the polarity of the membrane potential. At positive membrane potentials, the macroscopic toxin-induced current fluctuated at low
frequency, and inside-out patch recordings exhibited only one
elementary conductance of 22 pS. Thus, at positive membrane potentials,
the macroscopic TLY current is due to the summation of 22 pS
channel-like activities. However, at negative membrane potentials, the
macroscopic TLY current was complex and consisted of low and high
frequency components. The high frequency component was composed of
downward and upward macroscopic current steps, the former being more
frequent and exhibiting higher amplitudes than the latter. Thus, step
activity leads to a global downward deflection of the membrane current,
which is compensated for by an opposite behavior of the low frequency
component. This complex behavior was also observed at the channel
level, which revealed several conductance values and progressive
transitions combined with channel-like activity. Taken together, these
observations suggest that the macroscopic downward current steps result
from the opening of a large conductance that can close gradually or by
small steps. Another possibility is that elementary channels behave
independently at positive membrane potentials but that they cooperate
at negative potentials, with a higher cooperativity coefficient for
opening than for closing. The noise analysis of single channel
recordings (Fig. 7, E-E'), which revealed the existence of
a discrete event, together with the observation of various conductances
(all multiples of the discrete event) are in favor of the second hypothesis.
The influence of the membrane potential on the TLY-induced current at
the steady state revealed a strong outward rectification. In contrast,
fast ramp currents varied linearly with the membrane potential, which
indicates that the elementary conductance did not change with the
potential. Notably, current steps still occurred during ramp potentials
but only at negative potentials, and they led to abrupt changes in the
slope of the current (Fig. 5, bottom). Thus, the outward
rectification (Fig. 4B) is due to an increased number of
opened TLY-induced conductances overcompensating for the smaller
elementary conductance at positive potentials.
La3+ was found to block the TLY-induced current. However
its EC50 was about 5-fold higher for the TLY current than
has been reported (48) for voltage-sensitive Ca2+ channels
in the same cell line. Moreover, the voltage dependence of the
La3+ effect indicates that it acts via binding to a site
located in the pore formed by TLY. In addition, La3+
blockade was time- and concentration-dependent. Thus, at
100 µM the kinetics of the blockade of TLY action by
La3+ were slow enough to allow the TLY-induced conductance
opening to produce macroscopic downward current transitions, but they were sufficiently fast to block the TLY pore before its closing and to
hide the low frequency fluctuations.
The single-channel activity induced by TLY may result from the
formation of TLY channels with intrinsic gates oscillating between the open and closed state or from
oligomerization-deoligomerization of the TLY channels. Our results do
not allow us to distinguish between these two possibilities. The
complete amino acid sequence of TLY is not yet known, but its reported
(25) N-terminal amino acid sequence is similar to that of stonustoxin,
for which an amphiphilic -helix structure was predicted (49) for
each subunit. To explain the pore-forming property of stonustoxin, the
so-called "carpet-like" model (for review, see Ref. 50) has been
proposed (32). This model predicts the existence of a threshold amount of bound toxin for membrane permeation and an instability of the pore
structure. Our observations with TLY are in agreement with this model.
The ability of TLY to form cationic pores in the
cytoplasmic membrane of NG108-15 cells leads to membrane
depolarization, which in turn increases membrane permeation due to
outward rectification. Under normal conditions in which the membrane
potential is not controlled this mechanism of amplification leads to a
rapid and complete depolarization (51) that should induce activation of endogenous voltage-gated channels. However, previous experiments in our
laboratory found that low and high voltage-activated Ca2+
currents in NG108-15 cells were not modified by
TLY.2 In addition, the slight
participation of voltage-gated L, N, and P/Q Ca2+ channels
for TLY-induced catecholamine release from chromaffin cells (27) may
result from the depolarizing effect of the toxin. Considering the high
Ca2+ permeability of TLY pores and the potent increase in
membrane conductance induced by the toxin, the Ca2+ influx
through the pores would be expected to be large and to be higher than
Ca2+ influx through voltage-gated Ca2+ channels
in NG108-15 cells. Thus, the Ca2+ permeability of the
TLY-induced pores is sufficient to account for the external
Ca2+ dependence of the TLY-induced release of
neurotransmitters from motor nerve terminals and chromaffin cells
(25-27). Also, the elicited increase in Ca2+ permeability
may be responsible for mobilizing intracellular Ca2+ stores
in chromaffin cells (27). Moreover, the latent period between TLY
application and its increasing intracellular Ca2+ and
stimulating catecholamine release in chromaffin cells is similar to
that observed in the present studies of pore formation by TLY. Finally,
La3+, which inhibits NG108-15 cell membrane permeation by
TLY, also blocks the Ca2+ increase and catecholamine
secretion induced in chromaffin cells by TLY (27). Although the
Ca2+ permeability of the TLY pores may account for most of
the biological effects of TLY, it does not explain why TLY does not
trigger the release of large dense core vesicles containing
neuropeptides from motor nerve endings. Thus, further studies are
needed to explain this seeming paradox.
 |
ACKNOWLEDGEMENTS |
We thank Dr. B. Rouzaire-Dubois
for providing the NG108-15 cells used in this study, L. Prado de
Carvalho for assistance during preliminary experiments, L. Lane-Guermonprez for help with Western blotting, Dr. J.-M. Dubois and
the late Dr. R. Kado for critical discussions and comments on the
manuscript, and David McColm for assistance in helping to obtain the
S. trachynis venom used as the source of trachynilysin
needed in our study.
 |
FOOTNOTES |
*
This work was supported in part by the CNRS, by a grant from
the Direction des Systèmes de Forces et de la Prospective (to J. M.), and by National Institutes of Health Public Health Service Grant GM-43728 (to A. S. K.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by fellowships from the Ministère de l'Education
Nationale de la Recherche et de la Technologie and from the Association Française contre les Myopathies.
To whom correspondence should be addressed. Tel.:
33-169-82-36-42; Fax: 33-169-82-94-66; E-mail:
Jordi.Molgo@nbcm.cnrs-gif.fr.
Published, JBC Papers in Press, August 12, 2002, DOI 10.1074/jbc.M203433200
2
G. Ouanounou, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
-LTX, -latrotoxin;
TLY, trachynilysin;
EC50, effective
concentration (i.e. 50% of maximum).
 |
REFERENCES |
| 1.
|
Van der Kloot, W.,
and Molgó, J.
(1994)
Physiol. Rev.
74,
899-991[Free Full Text]
|
| 2.
|
Olivera, B. M.
(1997)
Mol. Biol. Cell
8,
2101-2109[Free Full Text]
|
| 3.
|
Schiavo, G.,
Matteoli, M.,
and Montecucco, C.
(2000)
Physiol. Rev.
80,
717-766[Abstract/Free Full Text]
|
| 4.
|
Südhof, T. C.
(2001)
Annu. Rev. Neurosci.
24,
933-962[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Ushkaryov, Y.
(2002)
Toxicon
40,
1-5[Medline]
[Order article via Infotrieve]
|
| 6.
|
Rosenthal, L.,
and Meldolesi, J.
(1989)
Pharmacol. Ther.
42,
115-134[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Bittner, M. A.,
Krasnoperov, V. G.,
Stuenkel, E. L.,
Petrenko, A. G.,
and Holz, R. W.
(1998)
J. Neurosci.
18,
2914-2922[Abstract/Free Full Text]
|
| 8.
|
Lang, J.,
Ushkaryov, Y.,
Grasso, A.,
and Wollheim, C. B.
(1998)
EMBO J.
17,
648-657[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Davletov, B. A.,
Meunier, F. A.,
Ashton, A. C.,
Matsushita, H.,
Hirst, W. D.,
Lelianova, V. G.,
Wilkin, G. P.,
Dolly, J. O.,
and Ushkaryov, Y. A.
(1998)
EMBO J.
17,
3909-3920[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Khvotchev, M.,
Lonart, G.,
and Südhof, T. C.
(2000)
Neuroscience
101,
793-802[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Ashton, A. C.,
Volynski, K. E.,
Lelianova, V. G.,
Orlova, E. V.,
Van Renterghem, C.,
Canepari, M.,
Seagar, M.,
and Ushkaryov, Y. A.
(2001)
J. Biol. Chem.
276,
44695-44703[Abstract/Free Full Text]
|
| 12.
|
Finkelstein, A.,
Rubin, L. L.,
and Tzeng, M. C.
(1976)
Science
193,
1009-1011[Abstract/Free Full Text]
|
| 13.
|
Robello, M.,
Fresia, M.,
Maga, L.,
Grasso, A.,
and Ciani, S.
(1987)
J. Membr. Biol.
95,
55-62[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Robello, M.
(1989)
Biochim. Biophys. Acta
978,
179-184[Medline]
[Order article via Infotrieve]
|
| 15.
|
Wanke, E.,
Ferroni, A.,
Gattanini, P.,
and Meldolesi, J.
(1986)
Biochem. Biophys. Res. Commun.
134,
320-325[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Hurlbut, W. P.,
Chieregatti, E.,
Valtorta, F.,
and Haimann, C.
(1994)
J. Membr. Biol.
138,
91-102[Medline]
[Order article via Infotrieve]
|
| 17.
|
Van Renterghem, C.,
Iborra, C.,
Martin-Moutot, N.,
Lelianova, V.,
Ushkaryov, Y.,
and Seagar, M.
(2000)
Eur. J. Neurosci.
12,
3953-3962[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Volynski, K. E.,
Meunier, F. A.,
Lelianova, V. G.,
Dudina, E. E.,
Volkova, T. M.,
Rahman, M. A.,
Manser, C.,
Grishin, E. V.,
Dolly, J. O.,
Ashley, R. H.,
and Ushkaryov, Y. A.
(2000)
J. Biol. Chem.
275,
41175-41183[Abstract/Free Full Text]
|
| 19.
|
Ushkaryov, Y. A.,
Petrenko, A. G.,
Geppert, M.,
and Südhof, T. C.
(1992)
Science
257,
50-56[Abstract/Free Full Text]
|
| 20.
|
Davletov, B. A.,
Krasnoperov, V.,
Hata, Y.,
Petrenko, A. G.,
and Südhof, T. C.
(1995)
J. Biol. Chem.
270,
23903-23905[Abstract/Free Full Text]
|
| 21.
|
Davletov, B. A.,
Shamotienko, O. G.,
Lelianova, V. G.,
Grishin, E. V.,
and Ushkaryov, Y. A.
(1996)
J. Biol. Chem.
271,
23239-23245[Abstract/Free Full Text]
|
| 22.
|
Krasnoperov, V. G.,
Beavis, R.,
Chepurny, O. G.,
Little, A. R.,
Plotnikov, A. N.,
and Petrenko, A. G.
(1996)
Biochem. Biophys. Res. Commun.
227,
868-875[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Krasnoperov, V. G.,
Bittner, M. A.,
Beavis, R.,
Kuang, Y.,
Salnikow, K. V.,
Chepurny, O. G.,
Little, A. R.,
Plotnikov, A. N., Wu, D.,
Holz, R. W.,
and Petrenko, A. G.
(1997)
Neuron
18,
925-937[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Lelianova, V. G.,
Davletov, B. A.,
Sterling, A.,
Rahman, M. A.,
Grishin, E. V.,
Totty, N. F.,
and Ushkaryov, Y. A.
(1997)
J. Biol. Chem.
272,
21504-21508[Abstract/Free Full Text]
|
| 25.
|
Colasante, C.,
Meunier, F. A.,
Kreger, A. S.,
and Molgó, J.
(1996)
Eur. J. Neurosci.
8,
2149-2156[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Ouanounou, G.,
Mattei, C.,
Meunier, F. A.,
Kreger, A. S.,
and Molgó, J.
(2000)
Cybium
24,
149-156
|
| 27.
|
Meunier, F. A.,
Mattei, C.,
Chameau, P.,
Lawrence, G.,
Colasante, C.,
Kreger, A. S.,
Dolly, J. O.,
and Molgó, J.
(2000)
J. Cell Sci.
113,
1119-1125[Abstract]
|
| 28.
|
Matteoli, M.,
Haimann, C.,
Torri-Tarelli, F.,
Polak, J. M.,
Ceccarelli, B.,
and De Camilli, P.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
7366-7370[Abstract/Free Full Text]
|
| 29.
|
Chameau, P.,
Meunier, F. A.,
Kreger, A. S.,
Shimahara, T.,
and Molgó, J.
(1997)
Toxicon
35,
1662
|
| 30.
|
Poh, C. H.,
Yuen, R.,
Khoo, H. E.,
Chung, M.,
Gwee, M.,
and Gopalakrishnakone, P.
(1991)
Comp. Biochem. Physiol. B
99,
793-798[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Garnier, P.,
Goudey-Perrière, F.,
Breton, P.,
Dewulf, C.,
Petek, F.,
and Perrière, C.
(1995)
Toxicon
33,
143-155[Medline]
[Order article via Infotrieve]
|
| 32.
|
Chen, D.,
Kini, R. M.,
Yuen, R.,
and Khoo, H. E.
(1997)
Biochem. J.
325,
685-691[Medline]
[Order article via Infotrieve]
|
| 33.
|
Hamprecht, B.
(1977)
Int. Rev. Cytol.
49,
99-170[Medline]
[Order article via Infotrieve]
|
| 34.
|
Rouzaire-Dubois, B.,
and Dubois, J. M.
(1990)
Cell. Signal.
2,
387-393[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Lowry, O. H.,
Rosebrourgh, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275[Free Full Text]
|
| 36.
|
Kreger, A. S.
(1991)
Toxicon
29,
733-743[Medline]
[Order article via Infotrieve]
|
| 37.
|
Hamill, O. P.,
Marty, A.,
Neher, E.,
Sakmann, B.,
and Sigworth, F. J.
(1981)
Pfluegers Arch. Eur. J. Physiol.
391,
85-100[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Rouzaire-Dubois, B.,
and Dubois, J. M.
(1990)
Pfluegers Arch. Eur. J. Physiol.
416,
393-397[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Robbins, J.,
and Sim, J. A.
(1990)
Pfluegers Arch. Eur. J. Physiol.
416,
130-137[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Goldman, D.
(1943)
J. Gen. Physiol.
27,
37-60[Abstract/Free Full Text]
|
| 41.
|
Hodgkin, A.,
and Katz, B.
(1949)
J. Physiol. (Lond.)
108,
37-77[Free Full Text]
|
| 42.
|
Chang, D. C.
(1983)
Biophys. J.
43,
149-156[Medline]
[Order article via Infotrieve]
|
| 43.
|
Valera, S.,
Hussy, N.,
Evans, R. J.,
Adami, N.,
North, R. A.,
Surprenant, A.,
and Buell, G.
(1994)
Nature
371,
516-519[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Orlova, E. V.,
Rahman, M. A.,
Gowen, B.,
Volynski, K. E.,
Ashton, A. C.,
Manser, C.,
van Heel, M.,
and Ushkaryov, Y. A.
(2000)
Nat. Struct. Biol.
7,
48-53[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Eisenberg, R. S.,
Frank, M.,
and Stevens, C. F.
(1984)
Membranes, Channels, and Noise
, Plenom Press, New York
|
| 46.
|
Belmonte, G.,
Pederzolli, C.,
Macek, P.,
and Menestrina, G.
(1993)
J. Membr. Biol.
131,
11-22[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Mirzabekov, T. A.,
Lin, M. C.,
and Kagan, B. L.
(1996)
J. Biol. Chem.
271,
1988-1992[Abstract/Free Full Text]
|
| 48.
|
Kasai, H.,
and Neher, E.
(1992)
J. Physiol. (Lond.)
448,
161-188[Abstract/Free Full Text]
|
| 49.
|
Ghadessy, F. J.,
Chen, D.,
Kini, R. M.,
Chung, M. C.,
Jeyaseelan, K.,
Khoo, H. E.,
and Yuen, R.
(1996)
J. Biol. Chem.
271,
25575-25581[Abstract/Free Full Text]
|
| 50.
|
Shai, Y.
(1995)
Trends Biochem. Sci.
20,
460-464[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Ouanounou, G.,
Malo, M.,
Kreger, A. S.,
Prado de Carvalho, L.,
and Molgó, J.
(1999)
Toxicon
37,
1234
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|